StockData
Lipocine Inc. logo

Lipocine Inc. (LPCN) stock

LPCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3042% below fair value
$1.52−0.08 (-5.00%)

Close on Nov 18, 2026Market cap $12.53MP/E –Yield –

Lipocine shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Lipocine's shares outstanding was 8M at Jun 30, 2026. For fiscal 2025 it was 6M, up 5.3% from the year before. Over ten years it grew 19.4% a year on average. The highest annual figure on record is 6M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20256M+5.3%
FY2024Dec 31, 20245M+2.9%
FY2023Dec 31, 20235M+0.3%
FY2022Dec 31, 20225M+2.0%
FY2021Dec 31, 20215M+57.3%
FY2020Dec 31, 20203M+115.2%
FY2019Dec 31, 20192M+21.2%
FY2018Dec 31, 20181M+6.5%
FY2017Dec 31, 20171M+9.8%
FY2016Dec 31, 20161M+10.9%
FY2015Dec 31, 20151M+29.0%
FY2014Dec 31, 20141M+73.4%
FY2013Dec 31, 20130M+65.2%
FY2012Dec 31, 20120M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 20268M+53.5%
Q1 FY2026Mar 31, 20267M+27.0%
Q4 FY2025Dec 31, 20257M+18.2%
Q3 FY2025Sep 30, 20255M+1.2%
Q2 FY2025Jun 30, 20255M+0.2%
Q1 FY2025Mar 31, 20255M-0.2%
Q4 FY2024Dec 31, 20246M+6.9%
Q3 FY2024Sep 30, 20245M+1.1%
Q2 FY2024Jun 30, 20245M+2.1%
Q1 FY2024Mar 31, 20245M+2.3%
Q4 FY2023Dec 31, 20235M+1.4%
Q3 FY2023Sep 30, 20235M+0.8%
Q2 FY2023Jun 30, 20235M-0.5%
Q1 FY2023Mar 31, 20235M+0.8%
Q4 FY2022Dec 31, 20225M+0.3%
Q3 FY2022Sep 30, 20225M+0.3%
Q2 FY2022Jun 30, 20225M+0.5%
Q1 FY2022Mar 31, 20225M+7.9%
Q4 FY2021Dec 31, 20215M+33.4%
Q3 FY2021Sep 30, 20215M+37.2%
Q2 FY2021Jun 30, 20215M+78.8%
Q1 FY2021Mar 31, 20215M+98.0%
Q4 FY2020Dec 31, 20204M+117.7%
Q3 FY2020Sep 30, 20204M+160.3%
Q2 FY2020Jun 30, 20203M+102.4%
Q1 FY2020Mar 31, 20202M+76.8%
Q4 FY2019Dec 31, 20192M+41.7%
Q3 FY2019Sep 30, 20191M+17.1%
Q2 FY2019Jun 30, 20191M+15.6%
Q1 FY2019Mar 31, 20191M+10.0%
Q4 FY2018Dec 31, 20181M+1.9%
Q3 FY2018Sep 30, 20181M+1.8%
Q2 FY2018Jun 30, 20181M+9.8%
Q1 FY2018Mar 31, 20181M+13.6%
Q4 FY2017Dec 31, 20171M+16.0%
Q3 FY2017Sep 30, 20171M+14.5%
Q2 FY2017Jun 30, 20171M–
Q1 FY2017Mar 31, 20171M–
Q4 FY2016Dec 31, 20161M–
Q3 FY2016Sep 30, 20161M–

More Lipocine figures

See a number that looks wrong?